Related Experiment Video
Updated: Jul 4, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Sensing estrogen's many pathways
1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, USA. rossw@pharmacy.purdue.edu
Abstract:
Estrogen receptor (ER) is an important drug target, but it has multiple signaling pathways that are difficult to dissect. A new study reports the development of a multicolor bioluminescent probe that can measure a compound's ability to modulate ER-mediated transcription and to promote an interaction between ER and Src, a key protein in a number of different cell signaling cascades. The discovery provides a new tool for quickly obtaining a more complete picture of the potential effects of a compound on estrogen signaling and could lead to more selective ER modulators with fewer side effects.
Insights
Researchers developed a novel bioluminescent probe to analyze estrogen receptor (ER) signaling pathways. This tool helps assess how compounds affect ER transcription and ER-Src protein interactions, aiding in the development of safer drugs.
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- Estrogen receptor (ER) is a critical drug target due to its role in various physiological processes.
- Dissecting the complex and multiple signaling pathways of ER remains a significant challenge in drug development.
- Understanding ER modulation is crucial for developing targeted therapies with reduced adverse effects.
Purpose of the Study:
- To develop a novel multicolor bioluminescent probe for studying estrogen receptor (ER) signaling.
- To assess a compound's ability to modulate ER-mediated transcription.
- To evaluate a compound's capacity to promote the interaction between ER and Src, a key signaling protein.
Main Methods:
- Development of a multicolor bioluminescent probe system.
- Utilizing the probe to measure ER-mediated transcriptional activity.
- Quantifying the interaction between ER and Src protein in response to compound treatment.
Main Results:
- The study successfully developed a bioluminescent probe capable of monitoring ER signaling.
- The probe can simultaneously measure ER transcriptional modulation and ER-Src protein complex formation.
- This provides a comprehensive method for evaluating compound effects on estrogen signaling pathways.
Conclusions:
- The novel bioluminescent probe offers a powerful new tool for dissecting ER signaling complexity.
- This discovery facilitates rapid assessment of compound interactions with ER and associated proteins.
- The findings may accelerate the development of more selective estrogen receptor modulators with improved safety profiles.
More Related Videos
Related Concept Videos
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Amplifying Signals via Second Messengers
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...

